Liquid Handling System for Automatic Particle Characterization

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2016
Volume 40
Issue 9

The FlowCam ALH automated liquid handling system from Fluid Imaging Technologies is a particle imaging and analysis system that automatically detects, images, and characterizes individual particles and microorganisms.

The FlowCam ALH automated liquid handling system from Fluid Imaging Technologies is a particle imaging and analysis system that automatically detects, images, and characterizes individual particles and microorganisms. The automated liquid handling system can process up to 96 samples per run without requiring human intervention. The system can be used for particle characterization and quality control in protein therapeutics, drug development, and production. The FlowCam autosampler includes built-in mixing, heating, and cooling for sample conditioning, control over evaporation, and protection against sample degradation. The system is self-contained in a protective enclosure suitable for cleanrooms.

Fluid Imaging Technologies
 

Articles in this issue
The Internet of Things for Pharmaceutical Manufacturing
The Internet of Things for Pharmaceutical Manufacturing
How to Get the Most Out of Facility Renovations
How to Get the Most Out of Facility Renovations
Root Cause Analysis–Finding the Root of the Problem
New Directions in Modular Manufacturing
New Directions in Modular Manufacturing
Efforts Accelerate to Streamline Postapproval Change Process
Common Deficiencies in ANDAs for Dermatologic Drug Products
Common Deficiencies in ANDAs for Dermatologic Drug Products
PT0916_troubleshoot_Fig1TypicalValve_300.jpg
Maintaining Hygienic Diaphragm Valves
Charles-Ross.jpg
Tumble Blenders Include Improved Safety Features
NovaBiomedical.jpg
Analyzer Automates Cell-Culture Chemistry Analysis
Omega.jpg
Data Logger Provides Ultra-Low Temperature Readings
Fluid-Imaging.jpg
Liquid Handling System for Automatic Particle Characterization
Sterile Injectables Shortages: Can Innovation End A Crisis?
Sterile Injectables Shortages: Can Innovation End A Crisis?
De-activating the Ticking Bomb of Brain Diseases with Nanomedicines
De-activating the Ticking Bomb of Brain Diseases with Nanomedicines
Taking a Closer Look at Parenteral Contaminants
Taking a Closer Look at Parenteral Contaminants
The Search for a Greener Fluorination Reaction
The Search for a Greener Fluorination Reaction
Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Sherwin-Williams to Showcase Next-Gen Coatings for Pharma Cleanrooms at INTERPHEX 2025

Feliza Mirasol
March 28th 2025
Article

Sherwin-Williams’ advanced coating systems are designed to ensure safety, sterility, and efficiency in pharma manufacturing environments.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Issues Warning Letter to Aspen Biopharma Labs for API Manufacturing Deviations

Feliza Mirasol
March 27th 2025
Article

In the latest of a series of warning letters to India-based API manufacturers, FDA issued a warning letter to Aspen for deviations in CGMP in the production of APIs.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Novartis’ Steady Investments in Slovenia Result in New Viral Vector Manufacturing Facility and a Growing Work Force

Feliza Mirasol
March 27th 2025
Article

With a completed €40 million (US$43 million) investment in Slovenia, Novartis has opened its first specialized viral vector production facility in Europe, following earlier significant investments in R&D that has led to the growth of Slovenia’s workforce.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

HHS Announces Restructuring

Susan Haigney
March 27th 2025
Article

In response to a presidential Executive Order, the Department of Health and Human Services is planning to reduce its workforce, including cutting FDA staff by 3500 full-time employees, and reorganize some key departments.